Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2010
03/24/2010CN101679257A Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/24/2010CN101678129A Radioactive pet agents for imaging CCR5 in vivo
03/24/2010CN101678009A Indolizine acetic acid derivatives as CRTH2 antagonists
03/24/2010CN101677569A 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
03/24/2010CN101676288A Iminazole chiral organic micromolecule compound with bicyclo-structure and synthesizing method thereof
03/24/2010CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676285A Azaindoles useful as inhibitors of JAK and other protein kinases
03/23/2010US7683225 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/18/2010WO2010030727A1 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
03/18/2010WO2010030538A2 Compounds for the treatment of hepatitis c
03/18/2010WO2010030500A1 Aza-benzimidazolone chymase inhibitors
03/18/2010WO2010030360A1 3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
03/18/2010WO2010029364A1 Compounds
03/18/2010WO2010029313A1 Antiinfective compounds
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010US20100069640 Novel compound having affinity for amyloid
03/18/2010US20100069637 CRYSTALLINE SALT FORMS OF A 5,6,7,8-TETRAHYDRO-1,2,4-TRIAZOLO[4,3-a]PYRAZINE DERIVATIVE
03/18/2010US20100069633 Paliperidone ketone
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069431 Imidazopyridine compounds
03/18/2010US20100069430 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
03/18/2010US20100069427 Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods
03/18/2010US20100069419 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/18/2010US20100069415 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
03/18/2010US20100069406 Aspartyl protease inhibitors
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069393 Method of treatment and agents useful for same
03/18/2010US20100069381 Gsk-3betainhibitor
03/18/2010US20100069360 Organic compounds
03/18/2010US20100069357 Pyrimidine compounds, compositions and methods of use
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069352 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo[5,4-c] pyridin-4-one derivatives and their use as mch receptor antagonists
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010CA2736522A1 Aza-benzimidazolone chymase inhibitors
03/17/2010EP2162455A2 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
03/17/2010EP2162454A1 Imidazopyridine kinase inhibitors
03/17/2010EP2162445A1 Heterobicyclic compounds as kinase inhibitors
03/17/2010EP2162443A2 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
03/17/2010EP2162132A1 Heterocyclic kinase modulators
03/17/2010EP2161996A1 Carboxamide heterocyclic cgrp receptor antagonists
03/17/2010EP1641423B1 Benzodiazepine cgrp receptor antagonists
03/17/2010CN101675056A Heterocyclic compounds and their use as pesticides
03/17/2010CN101675049A Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
03/17/2010CN101675048A 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
03/17/2010CN101675042A Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
03/17/2010CN101675041A Aminopyrimidines useful as kinase inhibitors
03/17/2010CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678911 1,6 naphthyridines useful as inhibitors of SYK kinase
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678825 Administering 2-[1-(3-Ethoxy-4-methoxyphenyl)2-methylsulfonylethyl]4,5-diaminoisoindoline-1,3-dione or salts to treat Crohn's disease, inflammatory bowel disease, psoriasis, rheumatoid arthritis, spondylitis, osteoarthritis, or ulcerative colitis; tumor necrosis factor and phosphodiesterase inhibitors
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678806 5-Bromo-1'-[(3-methyl-1H-inden-2-yl)carbonyl]spiro[indole-3,4'-piperidin]-2(1H); vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678801 Compounds
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678788 (1,4-Diaza-bicyclo[3.2.2]non-4-yl)-5-(4-nitrophenyl)-furan-2-yl-methanone; nicotinic acetylcholine receptor inhibitors; nervous system disorders, neurodegeneration, inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances
03/16/2010CA2437718C Carboline derivatives
03/11/2010WO2010028232A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/11/2010WO2010028033A1 Amides of diazabicyclooctanes and uses thereof
03/11/2010WO2010028011A1 Amides of diazabicyclononanes and uses thereof
03/11/2010WO2010027762A1 Indolizine inhibitors of leukotriene production
03/11/2010WO2010027567A2 Tricyclic spirocycle derivatives and methods of use thereof
03/11/2010WO2010027500A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010WO2010027424A2 9-substituted phenanthrene based tylophorine derivatives
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026208A1 1-aza-bicyclo[3.3.1]nonane or -3-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/11/2010WO2010026177A1 1,4-diaza-bicyclo [3.2.2] nonyl pyridine derivatives as nicotinic and monoamine receptor modulators
03/11/2010WO2010026176A1 1,4 -diaza- bicyclo [3.2.2]n0nyl pyrimidine derivatives as nicotinic and monoamine receptor modulators
03/11/2010WO2010026121A1 Bicyclic kinase inhibitors
03/11/2010WO2010026113A1 Acyl- and sufonyl tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
03/11/2010WO2010025872A2 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl
03/11/2010WO2010007114A3 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors
03/11/2010WO2010004197A3 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
03/11/2010WO2009026446A9 Hdac inhibitors
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063276 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2, and m3 receptors
03/11/2010US20100063118 Hydantoins Having RNase Modulatory Activity
03/11/2010US20100063088 Raf Kinase Inhibitors
03/11/2010US20100063087 5-Amino-4-Hydroxy-7-(Imidazo [1,2-A] Pyridin-6-Ylmethyl)-8-Methyl-Nonamide Derivatives and Related Compounds as Renin Inhibitors for the Treatment of Hypertension
03/11/2010US20100063082 Camptothecin derivatives with antitumor activity
03/11/2010US20100063068 Compounds for the Treatment of Hepatitis C
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063066 Raf inhibitor compounds and methods of use thereof
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063046 Tetracyclic imidazole analogs
03/11/2010US20100063032 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010US20100062046 Polymorphs of nicotinic intermediates
03/11/2010US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals
03/11/2010US20100060152 Phenanthroline compounds and electroluminescent devices using the same
03/11/2010US20100059716 Pentarylene-and hexarylenetetracarboximides and preparation thereof
03/11/2010CA2736275A1 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl
03/11/2010CA2736195A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
03/11/2010CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010CA2735795A1 Novel inhibitors
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 646